Medtech faces greatest polymer cost pressure as oil prices rise, says Deutsche Bank

Deutsche Bank has warned that consumables-heavy medical device companies face the greatest exposure to rising petrochemical input costs, as recent polymer price moves add a new layer of cost pressure across UK healthcare and life sciences. Analyst Kane Slutzkin notes that polypropylene and polyethene prices have risen around 35-40%, creating potential headwinds for companies whose products rely on polymer-based inputs.